Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder

European Urology

Volumn 41, Issue 3, 2002, Pages 342-345

  Basakci, Alper ^a   Kirkali, Ziya ^a   Tuzel, Emre ^a   Yorukoglu, Kutsal ^a   Mungan, M Ugur ^a   Sade, Murat ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Bladder; Estrogen receptors; Prognosis; Superficial transitional cell carcinoma

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR VOLUME;

CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN; URINARY BLADDER NEOPLASMS;

EID: 0036522516     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00038-6     Document Type: Article

References (17)

1. Lee R, Droller MJ. The natural history of bladder cancer: Implications for therapy. Urol Clin N Am 2000;27(1):1-13.
2. Schatte E, Gruenenfelder J, Fradet Y, Miles BJ. Epidemiology of bladder cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, editors. Genitourinary Oncology, 2nd Ed. Philadelphia: Lippincott Williams and Wilkins Company, 2000. p. 282-8.
3. Saez S, Martin PM. Evidence of estrogen receptors in the trigone area of human urinary bladder. J Steroid Biochem 1981;15:317-20.
4. Dunning WF, Curtis MR, Segaloff A. Strain differences in response to diethylstilbestrol and the induction of mammary gland and bladder cancer in rat. Cancer Res 1947;5:511-21.
5. Kvist E, Albrectsen J. Oestrogen receptor investigations in bladder tumors. Scand J Urol Nephrol 1994;28:369-70.
6. Noronha RFX, Rao BR. Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans. Urology 1986;28:401-3.
7. Kaufmann O, Baume H, Dietel M. Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique. J Pathol 1998;186:165-8.
8. Larocca LM, Giustacchini M, Maggiano N, Ranelletti FO, Piantelli M, Alcini E, et al. Growth-inhibitory effect of quercetin and presence of type II estrogen binding sites in primary human transitional cell carcinomas. J Urol 1994;152:1029-33.
9. Seymour L, Bezwoda WR, Meyer K, Behr C. Detection of p24 protein in human oestrogen exposure. Br J Cancer 1990;61:886-90.
10. TNM classification of malignant tumors, 5th ed. In: Sobin HL, Wittekind C, editors. Urogenital Tumors. New York: Wiley, 1997. p. 187-90.
11. Taylor CR, Cote RJ. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologists. Major Problems in Pathology Series, 2nd Ed. Philadelphia: WB Saunders Company, 1994.
12. Remmele W, Stegner HE. Recommendation for uniform definition of an immuno-reactive-score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologie 1987;8:138-40.
13. Kirkali Z, Cowan S, Leake RE. Androgen receptors in transitional cell carcinoma. Int Urol Nephrol 1990;22:231-4.
14. Reid LM, Leav I, Kwan PW, Russell P, Merk FB. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Cancer Res 1984;44:4560-73.
15. Cantor KP, Lynch CF, Johnson D. Bladder cancer, parity and age at first presentation. Cancer Causes Control 1992;3:57-62.
16. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Int Med 1998;128:705-12.
17. Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000;86:32-8.